Mark Lunderberg, MD, PhD

Dr. (Justin) Mark Lunderberg is a graduate of the Medical Scientist Training Program at the University of Chicago, where he earned his MD as well as a PhD in microbiology in the laboratory of Professor Olaf Schneewind. Here he studied the Bacillus anthracis cell envelope and the factors that allow the bacterium to form carbohydrate and protein layers important for virulence and necessary for the organism’s ability to cause anthrax disease. His doctoral work was supported by an NIH F30 National Research Service Award. Dr. Lunderberg subsequently completed his residency in anesthesiology and fellowship in critical care medicine at BIDMC in 2023. As faculty at BIDMC he has been supported by a mentored research training grant awarded by the Foundation for Anesthesia Education and Research (FAER-MTRG). Dr. Lunderberg is keenly interested in the impact of purinergic signaling pathways on ischemia-reperfusion injury.  Dr. Lunderberg’s focus, while mentored by Dr. Simon C. Robson, is to improve the mechanistic understanding of ischemia-reperfusion injury with the goal of translating this understanding to novel methods of organ protection, particularly in the perioperative period of liver graft transplantation.